Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport(®)) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

por Huynh Le Maux, Amélie, Pignol, Bernadette, Behr-Roussel, Delphine, Blachon, Jean-Luc, Chabrier, Pierre-Etienne, Compagnie, Sandrine, Picaut, Philippe, Bernabé, Jacques, Giuliano, François, Denys, Pierre
Publicado 2015